Skip to main content
. Author manuscript; available in PMC: 2024 Sep 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2024 May 13;120(1):149–161. doi: 10.1016/j.ijrobp.2024.03.020

Table 3.

Correlations between PRO measures and validity indicators at baseline

PRO measure Validity indicator
VAS Productivity
FACT-B trial outcome index 0.641
P < .001
n= 73
0.613
P < .001
n = 755
PROMIS fatigue −0.523
P < .001
n = 727
PROMIS anxiety −0.408
P < .001
n = 734
PROMIS ability to participate in social roles and activities 0.593
P < .001
n = 730
PRO-CTCAE severity of shortness of breath at its worst −0.191
P < .001
n = 751
PRO-CTCAE shortness of breath interferes with usual activities −0.260
P < .001
n = 727
PRO-CTCAE frequency of chest pain, chest tightness, or angina −0.199
P < .001
n = 751
PRO-CTCAE severity of chest pain, chest tightness, or angina at its worst −0.210
P < .001
n = 724
PRO-CTCAE chest pain, chest tightness, or angina interferes with usual activities −0.230
P < .001
n = 725

—: no associations between variables were expected or evaluated. For FACT-B, higher scores represent better health-related quality of life. For PROMIS, higher scores represent more of the outcome, eg, more fatigue, more anxiety, better ability. VAS ranges from 0 (worst imaginable health) to 100 (best imaginable health). Productivity represents a single item that assesses the extent that a patient was able to resume normal activities.

Abbreviations: FACT-B = Functional Assessment of Cancer Therapy-Breast; PRO = patient-reported outcome; PRO-CTCAE = Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events; PROMIS = Patient-Reported Outcomes Measurement Information System; VAS = Visual Analog Scale from the EQ-5D.